Elanco
在场
是其中之一......
Elanco 是一家在股票代码 ELAN (US) 下上市的公司。
Elanco 在 2 个国家有直接业务。
高管
查看带有其 37 名主要高管的组织结构图
Elanco 搜索最多的简介
- Jeffrey Simmons, President, Chief Executive Officer and Director
- Michael Harrington, Director
- David Hoover, Chairman of the Board (becomes Independent Director ...
高管在Elanco变化
- Craig Wallace已作为Director加入公司 (新闻发布的2024四月2号).
- Lawrence Kurzius 曾任 Director, 将于 20245月1 升职为 Chairman of the Board (新闻发布的2024一月3号).
创建提醒
跟踪 Elanco 的高管变动
药店
Elanco 拥有 1,865 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Elanco 的最新新闻稿
- Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
- Elanco Appoints Shiv O’Neill as General Counsel and Corporate Secretary
- Elanco Animal Health is Executing on Plan to Deliver for Shareholders
- Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
- Elanco Announces Sale of Aqua Business for $1.3 Billion
- Elanco Launches Multi-Year Mission to Save 1 Million Puppies from Canine Parvovirus
- Dairy Farmers of America Purchases First Verified Carbon Credits in Livestock Inset Marketplace
- Elanco Animal Health Announces Planned Board Leadership Changes and Corporate Governance Actions
- Elanco Animal Health Reports Third Quarter 2023 Results
- Athian and Elanco Animal Health Team Up to Transform Food Production
- View more press releases Close
通过电子邮件
